000 01195 a2200265 4500
005 20250518003541.0
264 0 _c20190923
008 201909s 0 0 eng d
022 _a1542-7714
024 7 _a10.1016/j.cgh.2018.06.022
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTaft, Tiffany H
245 0 0 _aThe Potential Role of Vedolizumab in Concomitant Eosinophilic Esophagitis and Crohn's Disease.
_h[electronic resource]
260 _bClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
_c11 2018
300 _a1840-1841 p.
_bdigital
500 _aPublication Type: Letter; Research Support, N.I.H., Extramural; Comment
650 0 4 _aAntibodies, Monoclonal, Humanized
650 0 4 _aCrohn Disease
650 0 4 _aEosinophilic Esophagitis
650 0 4 _aHumans
650 0 4 _aQuality of Life
700 1 _aMutlu, Ece A
773 0 _tClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
_gvol. 16
_gno. 11
_gp. 1840-1841
856 4 0 _uhttps://doi.org/10.1016/j.cgh.2018.06.022
_zAvailable from publisher's website
999 _c28961427
_d28961427